The revelation that a Tory trade minister secretly met a US drugs giant fuels concern that our NHS under Boris Johnson will be for sale to Donald Trump.
Alarm bells ring over George Hollingbery’s talks with insulin maker Eli Lilly, when the President has made clear he wants to charge countries such as Britain more and everything would be on the table in Brexit trade talks.
Leave the EU and Britain will be the weaker partner in negotiations with the US.
Trump is likely to put pharmaceuticals and selling chlorinated chicken among his top demands.
American giants resent the purchasing power of the NHS as its size allows our most precious public service to strike good deals.
Backdoor talks with US corporations are worrying and Johnson’s election campaign assurances need to be taken with a big pinch of salt when we know he is a cynical liar.
